Published in Arch Gen Psychiatry on October 01, 1994
Oxytocin: the great facilitator of life. Prog Neurobiol (2009) 3.71
Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett (2007) 2.38
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther (2011) 1.71
Oxytocin and the development of parenting in humans. Biol Psychiatry (2010) 1.50
Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry (2010) 1.47
The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry (2014) 1.18
Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms. Autism Res (2013) 1.01
Zebrafish orthopedia (otp) is required for isotocin cell development. Dev Genes Evol (2006) 0.95
A relationship between oxytocin and anxiety of romantic attachment. Clin Pract Epidemiol Ment Health (2006) 0.89
Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depress Anxiety (2012) 0.86
Three cases of symptom change in Tourette's syndrome and obsessive-compulsive disorder associated with paediatric cerebral malignancies. J Neurol Neurosurg Psychiatry (1996) 0.86
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders. Front Neurosci (2016) 0.83
Circadian rhythms in obsessive-compulsive disorder. J Neural Transm (Vienna) (2012) 0.82
The long-term psychiatric and medical prognosis of perinatal mental illness. Best Pract Res Clin Obstet Gynaecol (2013) 0.81
Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study. BMC Psychiatry (2013) 0.80
Dysregulation of neurosteroids in obsessive compulsive disorder. J Psychiatr Res (2008) 0.79
Oxytocin and psychological factors affecting type 2 diabetes mellitus. Exp Diabetes Res (2012) 0.79
A Case Series of Women With Postpartum-Onset Obsessive-Compulsive Disorder. Prim Care Companion J Clin Psychiatry (1999) 0.79
Brain functional connectivity during induced sadness in patients with obsessive-compulsive disorder. J Psychiatry Neurosci (2012) 0.78
The influence of oxytocin on volitional and emotional ambivalence. Soc Cogn Affect Neurosci (2014) 0.77
Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder. BMC Neurosci (2016) 0.75
Neurosteroid Levels in Patients with Obsessive-Compulsive Disorder. Psychiatry Investig (2015) 0.75
Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med (1989) 16.77
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA (1991) 9.71
Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry (1997) 7.10
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry (1989) 6.98
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry (1989) 6.80
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
Bipolar affective disorders linked to DNA markers on chromosome 11. Nature (1987) 4.64
Controlling health expenditures--the Canadian reality. N Engl J Med (1989) 4.36
Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature (1989) 4.18
Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol (1990) 3.88
A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull (1997) 3.84
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem (1994) 3.73
Recent findings on preventable hospitalizations. Health Aff (Millwood) (1996) 3.66
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol (1999) 3.39
Determinants of the increasing cesarean birth rate. Ontario data 1979 to 1982. N Engl J Med (1984) 3.16
What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ (2001) 3.15
Regionalization of cardiac surgery in the United States and Canada. Geographic access, choice, and outcomes. JAMA (1995) 3.12
Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry (1991) 3.02
Trends in use of medical services by the elderly in British Columbia. CMAJ (1989) 2.88
Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15. Am J Hum Genet (1997) 2.65
Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry (2008) 2.55
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry (2000) 2.48
The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med (1998) 2.48
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. J Am Acad Child Adolesc Psychiatry (1998) 2.30
The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med (1986) 2.30
The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry (2000) 2.29
Appropriateness in health care delivery: definitions, measurement and policy implications. CMAJ (1996) 2.27
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol (1999) 2.21
Reflections on a month in the life of the Ontario Drug Benefit Plan. CMAJ (1994) 2.20
Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol Psychiatry (2004) 2.19
Case-based reasoning and imaging procedure selection. Invest Radiol (1994) 2.19
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry (1991) 2.17
Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci U S A (1997) 2.11
Aspartame, behavior, and cognitive function in children with attention deficit disorder. Pediatrics (1994) 2.08
A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry (1996) 2.04
Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry (1994) 2.04
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice. J Thromb Haemost (2007) 2.00
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry (2001) 1.95
Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry (2000) 1.94
DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry (1995) 1.93
Symptoms of obsessive-compulsive disorder. Am J Psychiatry (1997) 1.88
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry (1986) 1.83
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
Coronary artery bypass grafting in Canada: What is its rate of use? Which rate is right? CMAJ (1992) 1.71
Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology (1993) 1.68
Patterns of practice among older physicians in Ontario. CMAJ (1998) 1.66
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry (1989) 1.66
A twin study of Tourette syndrome. Arch Gen Psychiatry (1985) 1.65
Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther (2002) 1.63
Chromosome 6p influences on different dyslexia-related cognitive processes: further confirmation. Am J Hum Genet (2000) 1.60
Hospitalization for ambulatory care-sensitive conditions: a method for comparative access and quality studies using routinely collected statistics. Can J Public Health (2001) 1.58
Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study. BJOG (2014) 1.58
Localized antimicrobial peptide expression in human gingiva. J Periodontal Res (2001) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry (1990) 1.56
A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish. Nat Genet (1996) 1.56
Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry (1994) 1.56
Incidence of diabetes among postmenopausal breast cancer survivors. Diabetologia (2012) 1.55
Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. J Am Acad Child Adolesc Psychiatry (1995) 1.55
Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. J Am Acad Child Adolesc Psychiatry (1997) 1.54
Flat on your back or back to your flat? Sources of increased hospital services utilization among the elderly in British Columbia. Soc Sci Med (1990) 1.53
Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior. J Nerv Ment Dis (1999) 1.52
Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry (1995) 1.52
Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology (1998) 1.51
Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry (1992) 1.49
Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology (1992) 1.48
The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med (2001) 1.48
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry (1998) 1.47
Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry (1993) 1.46
Trichotillomania. Presentation, etiology, diagnosis and therapy. Am J Clin Dermatol (2001) 1.46
A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol (1991) 1.45
A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry (2000) 1.44
The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology (1999) 1.44
Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry (2005) 1.44
D2 dopamine receptor alleles do not influence severity of Tourette's syndrome. Results from four large kindreds. Arch Neurol (1994) 1.43
Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry (1999) 1.43